Globe Newswire
CoinShares XBT Provider AB (publ)LEI: 549300HGWKR2Q5T8GK64
3 September 2026
CoinShares XBT Provider AB (publ)
Issuance Programme for the issue of
Bitcoin Tracker Certificates and Ethereum Tracker Certificates
Change of FX Rate/FX Source
CoinShares XBT Provider AB (publ) (the “Issuer”) announces that, due to a change in the FX price source used by Compass Financial Technologies SA (the “Calculation Agent”) or any other Calculation Agent specified in the Final... (continue reading...)
CoinShares XBT Provider AB (publ)LEI: 549300HGWKR2Q5T8GK64
3 September 2026
CoinShares XBT Provider AB (publ)
Issuance Programme for the issue of Bitcoin Tracker Certificates
Change of FX Source/FX Rate
CoinShares XBT Provider AB (publ) (the “Issuer”) announces that, due to a change in the FX price source used by Compass Financial Technologies SA (the “Calculation Agent”) or any other Calculation Agent specified in the Final Terms applicable to the relevant... (continue reading...)
CINCINNATI, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Hillman Solutions Corp. (Nasdaq: HLMN) (the “Company” or “Hillman”), a leading provider of hardware products, announced it has completed its previously announced acquisition of Kanebridge, LLC (“Kanebridge”), a leading master distributor of industrial fasteners, for a purchase price of approximately $315 million, subject to customary adjustments. The acquisition was first announced on August 3, 2026.
Kanebridge supplies... (continue reading...)
MIRABEL, Quebec, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSX: FLT) (OTCQX: TAKOF) (Frankfurt: ABB.F) (“Volatus” or the “Company”), a Canadian-headquartered global aerospace and defence company, today announced that it has been selected as a qualified supplier under the Government of Canada’s Defence Drone Initiative (DDI) Marketplace.
The qualification establishes Volatus as a pre-qualified supplier under the DDI Marketplace and provides the... (continue reading...)
TORONTO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company”), a leader in advancing North America’s critical minerals processing, today announced is upcoming schedule of investor and industry engagement for September as the Company continues to advance construction of its Ontario cobalt sulfate refinery and its broader North American critical minerals strategy.
Members of Electra’s... (continue reading...)
More Globe Newswire
View Older Stories-
FDA Grants Fast Track Designation to YUTREPIA® for the Treatment of Raynaud's Phenomenon Associated with Systemic Sclerosis
-
TG Therapeutics to Participate in the Cantor Global Healthcare Conference
-
Trevi Therapeutics to Participate in Upcoming September Conferences
-
ESGold Commences Diamond Drilling at Its Montauban Project, Québec
-
Helus Pharma to Participate at the 2026 Cantor Global Healthcare Conference in New York
-
Eikon Therapeutics Appoints Ching-Pin Chang, M.D., Ph.D. as Executive Vice President and Chief Scientific Officer
-
FDA Grants Fast Track Designation to YUTREPIA® for the Treatment of Raynaud's Phenomenon Associated with Systemic Sclerosis
-
Morocco Strategic Minerals Corp. Completes Sale of Initial 51% Interest in Sakami Property in Québec
-
Kobo Resources Extends Gold Mineralisation to the North at Kossou with Multiple High-Grade Drill Intercepts
-
Rekor Eliminates Approximately $10 Million in Liabilities and Generates More Than $2 Million in Annual Savings
-
Saia Provides July and August LTL Operating Data
-
Dyne Therapeutics to Present Preclinical Data for Multiple Development Candidates for Duchenne Muscular Dystrophy (DMD) at 27th Annual NMSG Scientific Meeting
-
Structure Therapeutics to Participate in Upcoming Healthcare Investor Conferences
-
Crescent Biopharma to Present at September Investor Conferences
-
MiniLuxe Announces New Mansfield Studio Opening Through Joint Venture with Entrepreneur Vera Vos-Lexmond
-
Wood Mackenzie: Natural Carbon Sinks Absorb 40% of Human CO2 Emissions and Are Not Valued in Most Climate Models
-
Amwell® receives Frost & Sullivan's 2026 Technology Innovation Leadership Recognition for addressing healthcare fragmentation
-
Kraig Biocraft Laboratories Highlighted by Tech Times for Advancing Spider Silk from Science Fiction Toward Commercial Reality
-
Amwell® receives Frost & Sullivan's 2026 Technology Innovation Leadership Recognition for addressing healthcare fragmentation
-
Alterity Therapeutics to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026
-
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
EdgeMode secures FINRA completion of Form 211 review, permitting sponsoring market maker to initiate quotations
-
Stallion Completes Ground Gravity, Identifies Three New Priority Target Areas At Stone Island
-
Rubicon Organics Announces Details of Annual General Meeting
-
Real Matters Announces Departure of Chief Financial Officer
-
CANADA’S FAVOURITE COOKIE BRAND CELEBRATES 25TH STORE OPENING IN PORT CREDIT MISSISSAUGA AS NATIONAL FRANCHISE EXPANSION ACCELERATES
-
BlossomHill Therapeutics to Present at the 8th Annual RAS-Targeted Drug Development Summit & H.C. Wainwright 28th Annual Global Investment Conference
-
GXO Expands Technology Organization To Enable Scale and Resilience and Accelerate Innovation
-
Newron Pharmaceuticals to Participate in H.C. Wainwright 28th Annual Global Investment Conference
-
Cartesian Therapeutics to Participate in Upcoming Investor Conferences
-
Victoria’s Secret & Co. Reports Second Quarter 2026 Results
-
Aurora Mobile Showcases AI Solutions for Customer Engagement at Tokyo’s AI Expo Summer 2026
-
Alternative Ballistics Appoints Sertan Ayçiçek to Help Drive Global Expansion, Strategic Investment and Commercial Growth
-
Eledon Pharmaceuticals Announces Islet Cell Transplantation IND Submission, First Patients Enrolled in Multiple Transplant Programs, and Reaffirms Plan to Initiate Phase 3 Kidney Transplantation Trial
-
Fate Therapeutics to Participate in Fireside Chat at the 2026 Annual Cantor Global Healthcare Conference
-
Gyre Therapeutics to Participate in Upcoming September Investor Conferences
-
C4 Therapeutics to Present New Biomarker Data on the Immunomodulatory Effects of Cemsidomide in Combination with Dexamethasone from its Phase 1 Relapsed/Refractory Multiple Myeloma Trial at the 23rd I
-
LeonaBio to Participate in Cantor Global Healthcare Conference 2026
-
Climb Bio Announces CLYM116 Phase 1 Data Demonstrating Prolonged Half-Life and Best-In-Class APRIL Suppression Supporting Every-12-Week Dosing in IgA Nephropathy
-
Breckenridge Distillery and Southern Glazer’s Expand Partnership Across New York and California
-
Medicenna to Present at the H.C. Wainwright 28th Annual Global Investment Conference
-
Avalo Therapeutics to Participate in Upcoming Investor Conferences
-
GXO Expands Technology Organization To Enable Scale and Resilience and Accelerate Innovation
-
BlossomHill Therapeutics to Present at the 8th Annual RAS-Targeted Drug Development Summit & H.C. Wainwright 28th Annual Global Investment Conference
-
Nu-Tek BioSciences’ Animal-Free Raw Materials Drive Cell Culture Media Evolution, Supply Security at CPHI Global 2026 in Milan
-
MT Højgaard Holding A/S: Enemærke & Petersen to refurbish Lærkeparken in Odense
-
ScottsMiracle-Gro to Acquire Black Kow in Alignment with SMG 2.0 Growth Strategy
-
ANI Pharmaceuticals to Present at September Investor Conferences
-
Pharvaris Presents Translational, Nonclinical, and Clinical Data at Bradykinin Symposium 2026
-
Lands’ End Announces Second Quarter Fiscal 2026 Results
